TP53 and melanoma: Zhu P et al. [68] found that Arnicolide D also exerted an antimelanoma effect, mainly by decreasing cell viability, inducing G2/M cell cycle arrest and apoptosis, and increasing the levels of the cell cycle regulatory proteins p53 and p21 in melanoma cells.